Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 53Leukemia, Myeloid, Acute 51Neoplasm Metastasis 45Carcinoma, Non-Small-Cell Lung 40Prostatic Neoplasms 36Breast Neoplasms 34Multiple Myeloma 31Colorectal Neoplasms 28Pancreatic Neoplasms 27Carcinoma, Renal Cell 25Melanoma 23Ovarian Neoplasms 21Myelodysplastic Syndromes 20Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 20Triple Negative Breast Neoplasms 19Burkitt Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Large B-Cell, Diffuse 17Urinary Bladder Neoplasms 16Squamous Cell Carcinoma of Head and Neck 16Carcinoma, Hepatocellular 16Glioblastoma 15Oropharyngeal Neoplasms 14Fallopian Tube Neoplasms 14Mouth Neoplasms 13Glioma 13Endometrial Neoplasms 13Carcinoma 13Lymphoma, Non-Hodgkin 12

Interventions

obeticholic acid 1Stents 1Specimen Handling 1Pancreaticojejunostomy 1Endoscopy, Gastrointestinal 1Biopsy 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Duodenal Neoplasms × Specimen Handling × 90 days × Clear all
NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡